
CAS 162635-04-3: Temsirolimus
Formula:C56H87NO16
InChI:InChI=1/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1
InChI key:InChIKey=CBPNZQVSJQDFBE-FUXHJELOSA-N
SMILES:O=C1N2[C@](C(=O)O[C@]([C@@H](C[C@H]3C[C@@H](OC)[C@H](OC(C(CO)(CO)C)=O)CC3)C)(CC(=O)[C@H](C)/C=C(\C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@@H](OC)C[C@]4(O[C@@](O)(C1=O)[C@H](C)CC4)[H])[H])(CCCC2)[H]
Synonyms:- (1R,2R,5S)-5-{(2S)-2-[(3S,6R,7E,9R,10R,12R,14S,15Z,17E,19E,21S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- 4-{2-[(7E,15Z,17E,19E)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- 40-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin
- Cci 779
- Ccl-779
- NSC 683864
- Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- Temsorolimus
- Torisel
- Way-Cci 779
- Temsirolimus
Sort by
Found 11 products.
Temsirolimus
CAS:Formula:C56H87NO16Purity:>95.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:1,030.30Temsirolimus (>80%)
CAS:Controlled ProductApplications Ester analog of Rapamycin. References Raymond, E., et al.: J. Clin. Oncol., 22, 2336 (2004), Galanis, E., et al.: J. Clin. Oncol., 23, 5294 (2005)Formula:C56H87NO16Purity:>80%Color and Shape:NeatMolecular weight:1030.29Temsirolimus
CAS:mTOR serine/threonine kinase inhibitorFormula:C56H87NO16Purity:Min. 95%Color and Shape:PowderMolecular weight:1,030.29 g/molTemsirolimus-d3
CAS:Controlled ProductApplications Labelled ester analog of Rapamycin. References Raymond, E., et al.: J. Clin. Oncol., 22, 2336 (2004), Galanis, E., et al.: J. Clin. Oncol., 23, 5294 (2005)Formula:C56H84D3NO16Purity:>85%Color and Shape:NeatMolecular weight:1033.31Temsirolimus-13C3,d7
CAS:Controlled ProductFormula:C3C53D7H80NO16Color and Shape:NeatMolecular weight:1040.308Temsirolimus
CAS:Temsirolimus (CCI-779) is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.Formula:C56H87NO16Purity:100% - 99.64%Color and Shape:White Crystalline PowderMolecular weight:1030.29